Qulipta 30 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FZX89
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,961
Award facts
- Contract value 100% obligated
- $4,961.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued on September 9, 2025, awards DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price contract valued at $4,961.28 for delivery of Qualipita 30 mg tablets (30-count supply). The award is issued without a set-aside designation and is funded by the Defense Logistics Agency (DLA), a Department of Defense logistics organization. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.99 billion contract vehicle valid through November 2026 that authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military health facility operations worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to consistently secure pharmaceutical delivery contracts with the DLA without set-aside designations. The company's portfolio encompasses branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across diverse therapeutic categories. This particular delivery order for Qualipita tablets represents a routine pharmaceutical supply fulfillment with an ultimate completion date of September 10, 2025, supporting the Department of Defense's healthcare supply requirements across military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FZX89?
SPE2DB25FZX89 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FZX89 worth?
The government has obligated $4,961 on SPE2DB25FZX89.
Is contract SPE2DB25FZX89 an order under another contract?
Yes. SPE2DB25FZX89 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX89 competed?
The extent of competition for SPE2DB25FZX89 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award